Hubei Fuxing Science and Technology Co.,Ltd
SZSE:000926 Stok Raporu
Hubei Fuxing Science and TechnologyLtd Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6 Hubei Fuxing Science and TechnologyLtd şirketinin toplam hissedar öz sermayesi CN¥13.0B ve toplam borcu CN¥5.8B olup, bu da borç-öz sermaye oranını 44.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥35.9B ve CN¥22.9B dir. Hubei Fuxing Science and TechnologyLtd 'in FAVÖK'ü CN¥430.0M faiz karşılama oranı 9.2 dur. Şirketin CN¥1.3B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler Faiz karşılama oranı 9.2x Nakit CN¥1.29b Eşitlik CN¥13.02b Toplam yükümlülükler CN¥22.89b Toplam varlıklar CN¥35.91b
Son finansal sağlık güncellemeleri
Tüm güncellemeleri göster
Third quarter 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.005 profit in 3Q 2023) Oct 31
Hubei Fuxing Science and Technology Co.,Ltd to Report Q3, 2024 Results on Oct 31, 2024 Sep 30
There's No Escaping Hubei Fuxing Science and Technology Co.,Ltd's (SZSE:000926) Muted Revenues Despite A 28% Share Price Rise Sep 27
New minor risk - Share price stability Sep 26
New major risk - Financial position Sep 20
Why Hubei Fuxing Science and TechnologyLtd's (SZSE:000926) Shaky Earnings Are Just The Beginning Of Its Problems Sep 06
Second quarter 2024 earnings released: CN¥0.024 loss per share (vs CN¥0.025 profit in 2Q 2023) Aug 31
Hubei Fuxing Science and Technology Co.,Ltd Approves Election of Ke Jiuming as Director Aug 10
Investor sentiment deteriorates as stock falls 20% Jul 25
New major risk - Revenue and earnings growth Jul 05
Hubei Fuxing Science and Technology Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 8 July 2024 Jul 02
Hubei Fuxing Science and Technology Co.,Ltd to Report First Half, 2024 Results on Aug 31, 2024 Jun 29
New major risk - Financial position May 29
Should You Think About Buying Hubei Fuxing Science and Technology Co.,Ltd (SZSE:000926) Now? May 22
Hubei Fuxing Science and Technology Co.,Ltd, Annual General Meeting, May 31, 2024 Apr 30
Hubei Fuxing Science and Technology Co.,Ltd's (SZSE:000926) Share Price Could Signal Some Risk Apr 17
Hubei Fuxing Science and Technology Co.,Ltd to Report Q1, 2024 Results on Apr 29, 2024 Mar 30
Hubei Fuxing Science and Technology Co.,Ltd (SZSE:000926) announces an Equity Buyback for 40,000,000 shares, for CNY 160 million. Feb 05
Hubei Fuxing Science and Technology Co.,Ltd (SZSE:000926) announces an Equity Buyback for 40,000,000 shares, for CNY 160 million. Feb 04
Investor sentiment deteriorates as stock falls 16% Feb 02
New minor risk - Shareholder dilution Jan 23
Third quarter 2023 earnings released: CN¥0.036 loss per share (vs CN¥0.014 loss in 3Q 2022) Jan 18
Hubei Fuxing Science and Technology Co.,Ltd to Report Fiscal Year 2023 Results on Apr 29, 2024 Dec 30
Less than half of directors are independent Nov 29
Third quarter 2023 earnings released: EPS: CN¥0.006 (vs CN¥0.014 loss in 3Q 2022) Nov 01
Second quarter 2023 earnings released: EPS: CN¥0.035 (vs CN¥0.04 in 2Q 2022) Aug 30
Investor sentiment improves as stock rises 18% Jul 27
Hubei Fuxing Science and Technology Co.,Ltd Announces Final Dividend on A Shares for the Year 2022, Payable on July 31, 2023 Jul 25
Hubei Fuxing Science and Technology Co.,Ltd, Annual General Meeting, Jun 02, 2023 May 17
First quarter 2023 earnings released: EPS: CN¥0.044 (vs CN¥0.04 in 1Q 2022) Apr 29 Hubei Fuxing Science and Technology Co.,Ltd announced that it expects to receive CNY 1.3 billion in funding Dec 06
Investor sentiment improved over the past week Nov 30
High number of new directors Nov 16
Third quarter 2022 earnings released: CN¥0.014 loss per share (vs CN¥0.005 loss in 3Q 2021) Oct 28
Second quarter 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.059 in 2Q 2021) Aug 31
Investor sentiment deteriorated over the past week May 27
Investor sentiment improved over the past week May 10
Hubei Fuxing Science and Technology Co.,Ltd Announces No Dividend for 2021 Apr 28
Full year 2021 earnings: EPS and revenues miss analyst expectations Apr 27
Less than half of directors are independent Apr 27
Investor sentiment improved over the past week Mar 22
Third quarter 2021 earnings released: CN¥0.005 loss per share (vs CN¥0.02 loss in 3Q 2020) Nov 01
Second quarter 2021 earnings released: EPS CN¥0.059 (vs CN¥0.13 in 2Q 2020) Aug 29
Hubei Fuxing Science and Technology Co.,Ltd Approves Cash Dividend Jun 01
Hubei Fuxing Science and Technology Co.,Ltd Proposes Final Dividend for the Year 2020 May 02
Full year 2020 earnings released: EPS CN¥0.32 (vs CN¥0.62 in FY 2019) May 01
Hubei Fuxing Science and Technology Co.,Ltd(XSEC:000926) dropped from S&P Global BMI Index Jan 28
New 90-day low: CN¥4.63 Jan 25
New 90-day low: CN¥4.77 Jan 07
New 90-day low: CN¥5.01 Dec 22
Third quarter earnings released Oct 30
New 90-day low: CN¥5.23 Oct 27
New 90-day low: CN¥5.27 Sep 30
Hubei Fuxing Science and Technology Co.,Ltd announced that it expects to receive CNY 3 billion in funding Sep 30
Hubei Fuxing Science and Technology Co.,Ltd announced that it has received CNY 3 billion in funding Sep 26
First half earnings released Sep 01
Hubei Fuxing Science and Technology Co.,Ltd to Report First Half, 2020 Results on Aug 29, 2020 Aug 13
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 000926 'nin kısa vadeli varlıkları ( CN¥25.6B ) kısa vadeli yükümlülüklerini ( CN¥17.0B ) aşıyor.
Uzun Vadeli Yükümlülükler: 000926 şirketinin kısa vadeli varlıkları ( CN¥25.6B ) uzun vadeli yükümlülüklerini ( CN¥5.9B ) aşmaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 000926 'nin net borç/öz sermaye oranı ( 34.6% ) tatmin edici olarak değerlendirilmektedir.
Borcun Azaltılması: 000926 'nin borç/öz sermaye oranı son 5 yılda 136.4% seviyesinden 44.6% seviyesine düştü.
Borç Kapsamı: 000926 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.
Faiz Kapsamı: 000926 'in borcuna ilişkin faiz ödemeleri EBIT ( 9.2 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.
Sağlıklı şirketleri keşfedin Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
